The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo
Open accessAbstract
We have investigated interferon as a mediator of hematopoietic suppression in bone marrow failure. Interferon production by stimulated peripheral blood mononuclear cells from patients with aplastic anemia was significantly higher than that observed in controls; spontaneous interferon production by these cells was also high for more than half of aplastic anemia patients. Circulating interferon, not detectable in normal individuals, was detected in 10 of 24 patients. Interferon is a potent inhibitor of hematopoietic cell proliferation and, therefore, may be the mediator of suppression in many in vitro models employing patients' cells and sera. The possible pathogenic importance of interferon in aplastic anemia was suggested by an increase in hematopoietic colony formation in vitro after exposure of bone marrow cells to antiinterferon antisera (277 +/- 71% increase for patients compared to 1.6 +/- 1.6% for normal individuals). Interferon levels in the bone marrow sera of aplastic anemia patients were high (mean = 203 international units (IU)/ml, n = 8), even in comparison to circulating levels in the same patients. Normal bone marrow sera also contained measurable interferon but at lower levels (41 IU/ml, n = 16), indicating that interferon may be a normal bone marrow product. High concentration of bone marrow interferon, possibly due to abnormal immunologic activity or a reaction to virus infection of the bone marrow, may mediate hematopoietic suppression in aplastic anemia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the pathogenesis is still not entirely understood, type I IFNs have been identified to be involved in the development of AA. 55”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin
Wheelock, Ε. F. (1965) · Science · doi:10.1126/science.149.3681.310 · Cited by 725
Camitta, B. M., Thomas, E. D., Nathan, D., Santos, G., Gordon‐Smith, E. C., Rp, G., Rappeport, J., & Storb, R. F. (1976) · Blood · doi:10.1182/blood.v48.1.63.63 · Cited by 566
Iscove, N. N., Senn, J. S., Till, J. E., & McCulloch, E. A. (1971) · Blood · doi:10.1182/blood.v37.1.1.1 · Cited by 483
Kasahara, T., Hooks, J. J., Dougherty, S. F., & Oppenheim, J. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1784 · Cited by 479
Gutterman, J. U., FINE, S., Quesada, J. R., Horning, S. J., Levine, J., Alexanian, R., Bernhardt, L., Kramer, M., Spiegel, H. E., Colburn, W. A., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-549 · Cited by 377
Broxmeyer, H. E., Lu, L., Platzer, E., Feit, C., Juliano, L., & Rubin, B. Y. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.3.1300 · Cited by 354
On the varied biologic effects of interferon
Gresser, I. (1977) · Cellular Immunology · doi:10.1016/0008-8749(77)90262-3 · Cited by 354
Immunologic Abnormalities in Patients Receiving Multiple Blood Transfusions
Gascón, P., ZOUMBOS, N. C., & YOUNG, N. S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-2-173 · Cited by 308
Self-citationHuman erythroid burst-forming unit: T-cell requirement for proliferation in vitro.
Nathan, D. G., Chess, L., Hillman, D. G., Clarke, B. J., Bréard, J., Merler, E., & Housman, D. E. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.147.2.324 · Cited by 307
Cited by
Sorted by citations
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
The Pathophysiology of Acquired Aplastic Anemia
Young, N. S., & Maciejewski, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361906 · Cited by 503
Self-citationDinarello, C. A., & Mier, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171506 · Cited by 476
Maciejewski, J. P., Selleri, C., Anderson, S. M., & Young, N. S. (1995) · Blood · doi:10.1182/blood.v85.11.3183.bloodjournal85113183 · Cited by 474
Self-citationFaulds, D. M., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.2165/00003495-199345060-00007 · Cited by 466
Metadata
- Authors
- Zoumbos, N. C., Gascon, P., Djeu, J. Y., & Young, N. S.
- ORCID
- Young, N S
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1985-01
- Volume
- 82
- Issue
- 1
- Pages
- 188-192
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC396997
- OpenAlex
- W2064632541
- Cited by
- 330
- References
- 35
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 10 · 2017: 7 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
- Keywords
- interferon, aplastic anemia, hematopoietic suppression, bone marrow failure, peripheral blood mononuclear cells, hematopoietic colony formation, immunological activity
- MeSH terms
- Anemia, Aplastic, Bone Marrow Cells, Hematopoiesis, Humans, Interferon-gamma, Isoantibodies, Monocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
